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ABSTRACT 
Objective: A simple, accurate, precise and specific zero, first, second order and area under curve spectrophotometric methods has been developed 
for determination of Cefixime Trihydrate in its tablet dosage form by using methanol as a solvent.  
Methods: (1) Derivative spectrophotometric methods: The amplitudes in the zero order derivative of the resultant spectra at 287 nm, first order 
derivative of the resultant spectra at 307 nm and second order derivative of the resultant spectra at 307 nm were selected to find out cefixime 
trihydrate in its tablet dosage form by using methanol as a solvent. 
(2) Area under curve (Area Calculation): The proposed area under the curve method involves measurement of area at selected wavelength ranges. 
Two wavelength ranges were selected 281-295 nm for estimation of cefixime trihydrate. 
Results: The linearity was found to be 5-25 μg/ml for cefixime trihydrate. The mean % recoveries were found to be 100.97%, 100.58%, 99.60% and 
101.14% of zero, first, second derivatives and area under curve method of cefixime trihydrate. For Repeatability, Intraday precision, Interday 
precision, % RSD were found to be 0.2106, 0.2901 and 0.22569,0.2571 for zero order, 0.0008,0.6438 and 5.7700,0.3201 for first order, 
5.2358,0.5701 and 0.0003,1.8601 for second order and 4.2571,0.7251 and 0.0582,1.2563 for area under the curve method respectively. Limit of 
Detection and Quantitation were found to be 0.42μg/ml and 1.35μg/ml for zero order, 0.416μg/ml and 0.952μg/ml for first order, 0.718μg/ml and 
2.314μg/ml for second order, 0.819μg/ml and 2.429μg/ml for area under curve method respectively. Assay results of market formulation were 
found to be 100.97%, 100.58%, 99.60% and 101.14% for zero order, first order, second order and area under the curve method respectively. The 
proposed method has been validated as per ICH guidelines and successfully applied to the estimation of cefixime trihydrate in its Tablet dosage 
form. 
Conclusion: The developed methods can be concluded as accurate, sensitive and precise and can be easily applied to the pharmaceutical 
formulation. 
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INTRODUCTION 
Cefixime Trihydrate is a third generation cephalosporin antibiotic. 
Chemically it is a 5-Thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylic 
acid, 7-[(2 amino-4thiazolyl) {(carboxymethoxy) imino] acetyle} 
amino] 3ethynyl-8-oxo-trihydrate [1, 2]. Cefixime Trihydrate 
clinically used in the treatment of susceptible infections including 
gonorrhea, otitis media, pharyngitis, lower respiratory-tract 
infections such as bronchitis and complicated and uncomplicated 
Urinary Tract Infection [3-5]. It is soluble in methanol and 0.1M 
NaOH, insoluble water and 0.1M HCl. Cefixime Trihydrate is effective 
against a wide spectrum of sensitive Gram–Ve, Gram+Ve and 
anaerobic bacteria pathogens including β-lactamase producing 
strains[6,7]. The antibacterial effect of cefixime results from 
inhibition of mucopeptide synthesis in the bacterial cell wall [8].  
It is under the category of β-Lactam Antibiotics/cell Wall inhibitor. It 
Acts by inhibiting an enzyme transpeptidase, involved in the 
building of bacterial cell walls [9, 10]. It is used in Biliary Tract 
Infections, Sinusitis and Peptic Ulcer. It is official in United State 
Pharmacopoeia (USP) and British Pharmacopoeia (BP). USP 
describes High Performance Liquid Chromatography (HPLC) method 
and BP describes HPLC method. Several analytical methods have 
been developed for the determination of Cefixime Trihydrate. In 
lecturer review, ciprofloxacin was determined by high performance 
liquid chromatography (HPLC), voltammetry, Spectrofluorimetric 
method, Biosensors, HPLC–MS/MS, Solid phase spectrophotometry, 
micro emulsion electro kinetic chromatography (MEEKC) 
method[11,12,13-15],Microbiological turbidimetric method 
Spectrophotometry, Micellar liquid chromatographic (MLC) 
electrophoresis, flow injection UV spectrophotometric [16-19], flow 
injection chemiluminescence (CL), thin-layer chromatography is 
established, with micelle solutions as mobile phases(Micelle TLC 
Fluorimetry). The Rayleigh light scattering technique, Derivative 
spectrophotometertric, and Fourier transform infrared 
spectrometric (FTIR) [20-24].  
To our notice, no UV-spectrophotometric method using zero, first, 
second order and area under the curve spectrophotometric method 
have been reported for the determination of Cefixime Trihydrate in 
bulk and tablets. Hence an attempt has been made to develop new 
zero, first, second order and area under the curve 
spectrophotometric methods for estimation of Cefixime Trihydrate 
in bulk and pharmaceutical formulations with good accuracy 
simplicity, precision and economy [25-27]. 
 
 
Fig. 1: Chemical structure of Cefixime Trihydrate 
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MATERIALS AND METHODS 
Apparatus and instrumentation 
A shimadzu 1800 UV/VIS double beam spectrophotometer with 1 
cm matched quartz cells were used for all spectral measurements. 
Single Pan Electronic balance (CONTECH, CA 223, India) was used 
for weighing purpose. Sonication of the solutions was carried out 
using an Ultrasonic Cleaning Bath (Spectra lab UCB 40, India). 
Calibrated volumetric glassware (Borosil®) was used for the 
validation study. 
Materials 
Reference standard of Cefixime Trihydrate API was supplied as gift 
sample by Cipala Health Care (Pune, India). Tablet sample with label 
claim 400 mg per tablet were purchased from local market Pune. 
Method development 
Preparation of standard and sample solutions 
Stock solution of 10μg/ml of Cefixime Trihydrate was prepared in 
methanol for zero, first second order and area under curve 
spectrophotometric analysis. The standard solutions were prepared 
by dilution of the stock solution with methanol in a concentration 
range of 5, 10, 15, 20 and 25μg/ml with methanol for zero, first 
second order and area under curve spectrophotometric methods. 
Methanol was used as a blank solution. 
 
Fig. 2: Zero/0th
Twenty tablets each containing 400 mg of Cefixime Trihydrate were 
weighed crushed to powder and average weight was calculated. 
Powder equivalent to 10 mg of Cefixime Trihydrate was transferred 
in 100 ml of volumetric flask. A 50 ml of methanol was added and 
sonicated for 15 minutes. Then solution was further diluted up to 
the mark with methanol. The solution was filtered using whatmann 
filter paper no. 41; first 5 ml of filtrate was discarded.  
 order derivative spectrum of cefixime trihydrate 
in methanol (10µg/ml) 
 
Assay procedure 
This solution was further diluted to obtain 10µg/ml solutions with 
water subjected for UV analysis using distilled water as blank. 
Appropriate dilutions were made with methanol from stock solution 








Fig. 4: second order derivative spectrum of cefixime trihydrate 
in methanol (10µg/ml) 
 
Table 1: Assay of tablet dosage form 
S. No. Methods Sample Sol. Conc. (µg/ml) Amount found (%)* Mean amount found (%)  %RSD* 
1 Zero order 10 97.14 97.22 97.13 97.16 0.034 
2 First order 10 98.04 98.07 98.08 98.06 0.021 
3 Second order 10 98.17 98.22 98.21 98.20 0.027 
4 Area under curve method 10 100.26 101.58 99.06 100.30 0.024 
*n=3, % RSD = % Relative Standard Deviation. 
 
RESULTS AND DISCUSSION 
The proposed zero, first, second and area under curve 
spectrophotometry method provides simple, specific, precise, accurate 
and reproducible quantitative analysis for determination of cefixime 
trihydrate. The method was validated as per ICH guidelines in terms of 
specificity, linearity, accuracy, precision, limits of detection (LOD) and 
quantification (LOQ), robustness and reproducibility. The proposed 
method can be used for routine analysis and quality control assay of 
cefixime trihydrate in bulk and tablet formulation. 
Validation parameter [28] 
The zero, first, second order and area under the curve method values 
spectra for Cefixime Trihydrate were recorded at the wavelength of 
287 nm, 307 nm, 307 nm and 281-295 nm respectively. 
Linearity and range 
Under the experimental conditions described, the graph obtained 
for zero, first second order and area under curve methods spectra 
showed the linear relationship. Regression analysis was made for 
the slope, intercept and correlation coefficient values. The 
regression equations of calibration curves were y=0.035x+0.009 
(r2=0.998) at 287 nm for zero order derivative spectrophotometry, 
y=0.001x+0.011 (r2=0.999) at 307 nm for first order derivative 
spectrophotometry, y=0.002x+0.08 (r2=0.996) at 307 nm for 
second order derivative spectrophotometry and y=0.014x+0.004 
(r2=0.999) at 281 nm-295 nm for area under curve 
spectrophotometry methods. The range was found to be 5-
25μg/ml for all zero, first, second order and area under curve 
spectrophotometric methods. 
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Fig. 5: Zero order derivative spectrum of cefixime trihydrate 
dosage form (10µg/ml) 
 
 
Fig. 6: First order derivative spectrum of cefixime trihydrate 
dosage form (10µg/ml) 
 
 
Fig. 7: Second order derivative spectrum of cefixime trihydrate 
dosage form (10µg/ml) 
 
 
















Fig. 12: Zero order derivatives overlay of cefixime trihydrate at 
diff. Concentration 
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Fig. 13: first order derivative overlay of cefixime trihydrate at 
diff. concentration 
Accuracy 
To study the accuracy of the proposed methods and to check the 
interference from excipients used in the dosage forms, recovery 
experiments were carried out by the standard addition method. The 
accuracy for the analytical method was evaluated at 80%, 100% and 
120% levels of 20µg/ml standard solution.  
For Zero, first, second order and area under curve methods 
derivative were measured in the wavelength range at 287 nm, 307 
nm, 307 nm and 281 nm-295 nm respectively and the results were 
obtained in terms of the percent recovery. Three determinations at 
each level were performed and % RSD was calculated for each level. 
The accuracy of Cefixime Trihydrate was carried out as percent 
recovery shown in table 3. 
 
Table 2: Stastical data for the calibration graphs for determination of Cefixime Trihydrate by Proposed methods 
Parameters Zero order First order Second order Area under curve methods 
Linearity range (µg/ml)* 5-25 5-25 5-25 5-25 
r2 0.998 ±S. D* 0.999 0.996 0.999 
 

























































80 15 12 27 98.92 102.02 98.63 101.12         
 15 15 30 101.39 99.17 98.71 102.47 100.97 100.58 99.60 101.14 0.926 0.833 0.851 1.512 
120 15 18 33 102.61 100.54 101.48 99.85         
*n=3, % RSD = % Relative Standard Deviation. 
 
Table 4: Results of intra and inter day precision 
Parameters Intra Day Precision Inter Day Precision 
S. D* % RSD* S. D* % RSD* 
Zero order 0.2106 0.2901 0.2569 0.2571 
First order 0.0008 0.6438 5.7700 0.3201 
second order 5.2358 0.5701 0.0003 1.8601 
Area under curve  4.2571 0.7251 0.0582 1.2563 
 
Precision 
To determine the precision of the method, Cefixime Trihydrate 
solutions at a concentration of 10μg/ml were analysed each three 
times for all zero, first, second order and area under curve 
spectrophotometric methods. Solutions for the standard curves 
were prepared fresh every day. The intraday precision and interday 
precision were expressed in terms of relative standard deviation 
(RSD). For intraday & interday precision, % RSD for Cefixime 
Trihydrate was found to be satisfactory shown in table 4. 
Sensitivity 
The Limit of Detection (LOD) is the smallest concentration of the 
analyte that gives the measurable response. LOD was calculated 
using the following formula 
LOD = 3.3σ/S 
The Limit of Quantification (LOQ) is the smallest concentration of 
the analyte, which gives response that can be accurately quantified. 
LOQ was calculated using the following formula 
LOQ = 10σ/S 
Where, σ is standard deviation of the response and 
S is the slope of the calibration curve. 
The proposed method was evaluated statistically. The LOD and 
LOQ were found to be 0.42μg/ml and 1.35μg/ml for zero order 
derivative, 0.416µg/ml and 0.952µg/ml for first order derivative, 
0.718µg/ml and 2.314µg/ml for second order derivative and 
0.819µg/ml and 2.429µg/ml area under curve method 
respectively. The summary of validation parameter was shown 
in table 5.  
 
Table 5: Summary of validation parameters 
Parameter 0th 1/First derivative st 2 derivative nd AUC  derivative 
λ range 200-400 nm 200-400 nm 200-400 nm 200-400 
Regression Equation (y=mx+c) Y=0.035x+0.009 Y=0.001x+0.011 Y=0.002x+0.08 Y=0.014x+0.004 
Measured wavelength 287 nm 307 nm 307 nm 287 nm 
Linearity range 5-25µg/ml 5-25µg/ml 5-25µg/ml 5-25µg/ml 
Slope 0.035 0.001 0.002 0.014 
Intercept 0.009 0.011 0.08 0.004 
Correlation coefficient (R2 0.998 ) 0.999 0.996 0.999 
Limit of Detection (LOD) µg/ml 0.42 0.416 0.718 0.819 
Limit of Quantitation (LOQ) µg/ml 1.35 0.952 2.314 2.429 
Accuracy (Mean % Recovery) 100.97 100.58 99.60 101.14 
Precission (%RSD) 0.926 0.833 0.851 1.512 
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Analysis of the marketed formulation 
There was no interference from the excipients commonly present in 
the tablets. The drug content was found to be 100.82%, 98.13%, 
101.24% and 99.78% for zero, first, second order derivative and 
area under curve spectrophotometric methods respectively. It may 
therefore be inferred that degradation of Cefixime Trihydrate had 
not occurred in the marketed formulations that were analysed by 
this method. The low % R. S. D. value indicated the suitability of this 
method for routine analysis of Cefixime Trihydrate in 
pharmaceutical dosage form. The method was successfully applied 
to tablet formulation. The results are shown in table 5. 
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